Dermapharm SE Laborant bei der Arbeit mit Geräten

 

The Company

 

Company Profile

Dermapharm - Pharmaceutical Excellence
“Made in Germany”

Dermapharm is a rapidly growing manufacturer of branded pharmaceuticals. Founded in 1991, the Company is based in Grünwald near Munich. The Company's integrated business model comprises in-house development, production and the distribution of brand products by a trained pharmaceutical sales force. In addition to its main location in Brehna near Leipzig, Dermapharm also operates other production, development and distribution locations in Europe (primarily in Germany) and the United States.

In the "Branded pharmaceuticals and other healthcare products" segment, Dermapharm has approximately 1,300 marketing authorisations with more than 380 active pharmaceutical ingredients. Dermapharm's portfolio of pharmaceuticals, medical devices and food supplements are tailored to selected therapeutic areas in which the Company is a market leader, especially in Germany.

In the "Herbal extracts" segment, Dermapharm can tap the expertise of the Spanish company Euromed S.A., a leading global manufacturer of herbal extracts and plant-based active ingredients for the pharmaceuticals, nutraceuticals, foodstuffs and cosmetics industries. Since the beginning of 2022, the segment has been complemented by the German C³ Group, which develops, produces and markets natural and synthetic cannabinoids. The C³ Group is the market leader for dronabinol in Germany and Austria.

Dermapharm's business model also includes the "Parallel import business" segment that operates under the "axicorp" brand. Based on revenue, axicorp was among the top five parallel import companies in Germany in 2021.

With a consistent R&D strategy and numerous successful product and company acquisitions and by stepping up its internationalisation efforts, Dermapharm has continuously optimised its business over the past 30 years and sought external growth opportunities in addition to organic growth. Dermapharm is firmly committed to continuing on this profitable growth course in the future.

 

Management Board

Members of the Management Board

DR. HANS-GEORG FELDMEIER

CEO, PHARMACIST

Dr. Hans-Georg Feldmeier is the Chairman of the Management Board at Dermapharm. He joined the company in 2003 as project manager and was responsible for the construction of the new production facilities in Brehna. Since 2009, he has been Chief Production & Development Officer of Dermapharm. Dr. Feldmeier began his professional career in 1987 at Berlin Chemie. He played a decisive role in the modernization of the company after the fall of the Berlin Wall. In 2002, he was head of the supply center at Schering Aktiengesellschaft, Berlin.

Photo: ©BPI Kruppa

Dermapharm SE Foto von Dr. Hans-Georg Feldmeier

KARIN SAMUSCH

CBDO

Karin Samusch is Dermapharm’s Chief Business Development Officer. She joined the company in 1991 and has been responsible for business development, international affairs, regulatory affairs and pharmacovigilance ever since. Prior to joining Dermapharm she worked for the pharmaceutical company Dorsch GmbH and the seal producer Feodor Burgmann GmbH & Co. KG.

Dermapharm SE Foto von Vorstandsmitglied Karin Samusch

DR. JÜRGEN OTT

CMO

Since October 1, 2019 is Dr. Jürgen Ott is the Chief Marketing Officer, responsible for Marketing and Sales at Dermapharm. He holds a doctorate in chemistry and has extensive experience in the consumer goods and pharmaceutical industries. His last position since 2010 was Head of Marketing Germany, since 2014 Head of Marketing & Sales Germany and from 2017 Regional Head Central Europe at Bionorica SE, a manufacturer of herbal pharmaceuticals. Prior that he spent more than 11 years as Key Account Manager and Brand Manager at Procter & Gamble.

Dermapharm SE Foto von Vorstandsmitglied Dr. Jürgen Ott

HILDE NEUMEYER

CFO, CCO

Hilde Neumeyer has been Chief Financial Officer of the Dermapharm Group since July 1, 2020. She has been Chief Compliance Officer since the IPO and has developed a Governance, Risk & Compliance System as well as successfully established it within the Group. She has been working for Dermapharm in Finance and Accounting since October 1, 2000 and took over as Head of Group Accounting in 2005. Through the development of the accounting department, she has permanently and systematically adapted to new challenges and successfully integrated various acquisitions into the Group's reporting structures. Before joining the Dermapharm Group, Ms. Neumeyer worked for Novartis in accounting for 10 years.

Dermapharm SE Foto von Vorstandsmitglied Hilde Neumeyer

Supervisory Board

Members of the Supervisory Board

 

WILHELM BEIER

Wilhelm Beier was born in Eicherscheid (Bad Münstereifel), Germany, on April 21, 1956. Starting his career in 1981, he held various positions in the pharmaceuticals industry, including a managing director of the German subsidiaries of an international pharmaceuticals manufacturer. After founding Dermapharm in 1991, Mr. Beier served as Chief Executive Officer of Dermapharm AG.

In 2017, he was appointed chairman of the supervisory board of Dermapharm.

Mr. Beier and his family hold the majority of the company's shares via Themis Beteiligungs AG.


DR. ERWIN KERN

Dr Erwin Kern was born on July 6, 1960 in Karlsruhe, Germany. In 1986, Dr. Kern completed his studies in business administration at the Ludwig Maximilian University in Munich. In 1989, he received his doctorate in economics from the University of Paderborn. Dr. Kern began his professional career in 1986 as Managing Director of HBK-Handel und Beteiligungen Kern GmbH & Co. KG. From 1991 onwards, he was a member of the management of Kies und Beton Baden-Baden GmbH & Co. Holding KG and Kies und Beton AG Baden-Baden. In 2007, Dr. Kern took over the chairmanship of the management of these companies, which he still holds today. Since 2003, he has been President of the Federal Association of the German Ready-Mixed Concrete Industry (BTB). (BTB) since 2003 and was Chairman from 2008 to 2011 and Vice Chairman from 2011 to 2013 of Construction Products Europe (CPE) (Association of European Construction Materials Manufacturers).

Dr Kern was appointed as a member of the Supervisory Board of Dermapharm Holding SE in 2017. In addition to his position at Dermapharm, Dr Kern was and is active in various companies and associations in the stone and earth industry that are not listed on the stock exchange.


LOTHAR LANZ

Lothar Lanz was born on October 1, 1948 in Bihlafingen, Germany. From 1969 to 1974, Mr. Lanz studied business administration at the universities of Stuttgart and Berlin and graduated with a degree in business administration. Mr. Lanz began his professional career as an audit assistant for an auditor and tax consultant in Berlin. In 1977, Mr. Lanz joined Bayerische Hypotheken- und Wechselbank AG, where he served as branch manager from 1983 to 1990. In 1991, Mr. Lanz became a member of the Board of Management of H.S.B. HYPO Service-Bank AG, Munich. In 1996, he moved to Nassauische Sparkasse, Wiesbaden, where he also became a member of the Board of Management. In the same year, Mr. Lanz moved to the then ProSieben Media AG (now ProSiebenSat.1 Media AG) as Chief Financial Officer, a post he held until 2008. From 2009 to 2014, Mr. Lanz was a member of the Executive Board of Axel Springer AG (now Axel Springer SE), where he served as Chief Financial and Operating Officer.

Mr. Lanz was appointed as a member of the Supervisory Board of Dermapharm Holding SE in 2017. In addition, he is currently Chairman of the Supervisory Board of Home 24 SE, a member of the Supervisory Board of TAG Immobilien AG and the unlisted Bauwert AG as well as Chairman of the Board of Directors of the unlisted SMG Swiss Marketplace Group AG. Until 2019, he was also a member of the Supervisory Board of Axel Springer SE and Chairman of the Supervisory Board of Zalando SE

Locations

Our locations

Subsidiaries

Overview of subsidiaries

In the overview you will find our subsidiaries with focus on our company brands and groups within the Dermapharm Group. If required, further locations of these company brands abroad can be shown if available. The detailed organization chart of the Group structures and interests can be found on page 36 of the Annual Report 2021.

 

Branded pharmaceuticals

acis® Arzneimittel GmbH

acis® - a modern pharmaceutical company. Our mission is Our mission is health, our drugs are generics, our passion is quality. What the future brings, we determine through our actions in the present. The added value of our medicines is at the heart of everything we do. Our contribution ensures that the benefits of the generic drug idea are sustainable. The product range currently includes 40 active ingredients for the therapy of a wide variety of clinical pictures ranging from allergies to epilepsy.

to the website

Allergopharma

At Allergopharma, we have 50 years of experience in researching and treating allergies. We are the specialist for subcutaneous immunotherapy (SCIT) and the market leader in this field in Germany. For SCIT, we offer a wide range of high-dose, hypoallergenic preparations, so-called allergoids. In addition, our portfolio includes a wide range of allergens for diagnostics.

Dermapharm

Dermapharm is a fast-growing manufacturer of branded pharmaceuticals. Founded in 1991, the company is based in Grünwald near Munich. The company's integrated business model comprises in-house development and production as well as the distribution of branded products by a pharmaceutically trained sales force. In addition to the main site in Brehna near Leipzig, Dermapharm operates further production, development and sales sites within Europe, primarily in Germany, as well as in the USA.

Farmal BH d.o.o.

Gynial® AG

Gynial® was founded in 2007 in Austria. Since 2016, we have also been there for you in Switzerland. 100 years of experience in the pharmaceutical health care sector - this is the result if you add up the years of all Gynial employees in the pharmaceutical sector.

Hasan Dermapharm Co. Ltd.

HASAN - DERMAPHARM JOINT VENTURE CO., LTD is located in Thuan An, Binh Duong, Vietnam and is part of the Pharmaceutical and Medicine Manufacturing Industry. HASAN - DERMAPHARM JOINT VENTURE CO., LTD has 300 total employees across all of its locations.

to the website

mibe

mibe GmbH Arzneimittel is a high-performance, medium-sized pharmaceutical manufacturer that has been developing and producing quality preparations in a state-of-the-art pharmaceutical plant in the Leipzig/Halle area since 2003. Almost all products marketed by the Dermapharm Group are produced there. This is a clear commitment to Germany as a business location.

Strathmann GmbH & Co. KG

We are a medium-sized company with a Hanseatic attitude, a family spirit and a successful history. The founder and name giver was Dr. med. Detlef Strathmann. Since the very beginning we have been Hamburgers, cosmopolitan and at the same time connected to Germany as a business location: Our medicines are produced in Germany with high quality and short delivery routes, and the active ingredients come predominantly from Europe. Since 2018, we have been part of the Dermapharm AG group of companies.

to the Website

SUN-FARM Sp. U. o. O

The company produces and distributes pharmaceuticals, medical devices and food supplements for humans and animals. The main areas of activity are steroids, dermatics and painkillers. It was founded in 1991. Currently, it employs about 90 people. The main products are: Dekristol, Psotriol, Myditin, Drotafemme, Momecutan. Sun Farm has its own wholesalers with direct sales to pharmacies and also produces food supplements for humans and small animals.

to the Webseite

Trommsdorff GmbH & Co. KG

Trommsdorff is a modern medium-sized company for the production, galenic development and distribution of medicinal products, food supplements and complementary balanced diets. In addition, Trommsdorff also sells medical products. Challenges have always been the driving force for new developments at Trommsdorff. The affiliation to the Dermapharm Group strengthens the company for the requirements of the globalised markets. Today Trommsdorff operates with a broader, international perspective and uses the synergy effects within the Dermapharm network. This also inspires Trommsdorff's innovative strength, increases growth and efficiency - to the benefit of the customers.

to the Website

CORAT Therapeutics GmbH

CORAT Therapeutics GmbH is a clinical phase biopharmaceutical company dedicated to develop therapeutic products to fight SARS-CoV-2 mediated COVID-19. CORAT was founded as a spin off from the recombinant antibody development company Yumab GmbH. It´s most advanced clinical product, the antibody COR-101, was discovered in the lab of Prof. Dr. Stefan Dübel and Prof. Dr. Michael Hust at the Braunschweig University of Technology.

to the Website

Medical products

mibeTec

MibeTec US, Inc. is part of mibeTec GmbH, Germany. mibeTec GmbH is a high-quality medical device manufacturer that is actively developing and manufacturing superior products in state-of-the-art medical device laboratories and factories in Germany. The products of mibeTec have been marketed for over 20 years in Germany and today are available in 25 countries worldwide.

Natural remedies

Anton Hübner GmbH & Co. KG

HÜBNER products are manufactured both according to traditional recipes with their tried and tested active ingredients and according to the latest scientific findings. Today, highly motivated employees ensure the continuity of the company as well as the product and quality philosophy. According to the motto "Tradition and innovation meet in Ehrenkirchen", new developments are pursued in addition to the improvement of existing products. HÜBNER products combine a high degree of quality, effectiveness and compatibility according to nature's recipe and are suitable for the whole family.

To the website

Hübner Naturarzneimittel GmbH

HÜBNER Naturarzneimittel GmbH is a company of the Dermapharm Group based in Ehrenkirchen and operated under the name MEDOPHARM Arzneimittel GmbH & Co. KG. It is a medium-sized company that was founded in Munich in 1932 and has stood for natural preparations from pharmacies for many decades. HÜBNER Naturarzneimittel GmbH is the market leader in the field of silica products in pharmacies and offers an innovative range of natural-based products. With pharmaceutical precision, not only medicinal products and medical devices, but also food supplements and cosmetics are developed and produced in Germany.

to the Website

More health products

Fitvia GmbH

The healthy lifestyle start-up fitvia from Wiesbaden sells healthy food and dietary supplements in the area of healthy living via its own online shop - from tea to muesli to a broad product portfolio in the categories of weight control, wellness, beauty and healthy nutrition.

to the Website

Bellavia GmbH

Bellavia was developed for all women who know that standing still will get them nowhere and don't have time to waste on ineffective products. For women who believe that natural active ingredients are the rule and not the exception. And for those who seek a moment of relaxation and pleasure in a life full of daily commitments and responsibilities.

to the Website

Tiroler Nussöl Sonnenkosmetik GmbH (AT)

Tiroler Nussöl is not just any sun cosmetic - but rather the epitome of it. Nowhere are tradition, passion and joie de vivre so close together as in the brand with the Tyrolean eagle. For over 100 years, the oil with the extract of the green walnut shell has stood for sun protection with natural light protection. It once became the most popular sun oil in Austria and Germany. Tyrolean walnut oil gives a long-lasting, deep tan. And surrounds a person with that certain something. Whether in Kitzbühel, St. Moritz or on the Côte d'Azur - or in the garden at home.

to the Website

BLBR GmbH

The Uniqe™ system includes everything you need for easy and reliable dental care.

to the Website

Wellster Healthtech

Wellster Healthtech solves everyday medical undersupplies by giving people new access to effective treatment options.

To the Website

Other production plants

MELASAN Produktions- und Vertriebsges.m.b.H.

For 25 years, we have been developing and producing a wide range of diverse products and services with and for our clients. Thanks to our long-standing strategic partnerships with pharmacies, we are considered the hidden champion of private label manufacturers in the Austrian OTC market. In addition to large market suppliers, many small companies, start-ups or (online) shop operators in the DACH region are among our customers.

to the Website

axicorp Group

We are one of the leading experts in the parallel import and re-import of EU medicines and an expanding manufacturer of German-made over-the-counter medicines. In this context, the trust factor is particularly important throughout the entire value chain: both between patient and pharmacist and between pharmacist, business partners and us. Together, we pursue a course that is geared towards safe and good healthcare in order to support a functioning healthcare system.

Euromed Group

Founded in 1971 by German pharmaceutical group Madaus, Euromed is a GMP-certifed, leading manufacturer of premium-quality, gold-standard botanical extracts to support health and well-being. In 2019, Euromed was acquired by the renowned German pharmaceutical group Dermapharm.

C³ Cannabinoid Compound Company GmbH

As the market leader for dronabinol in Germany, the C³ Group develops, produces and markets natural and synthetic cannabinoids and also occupies a leading market position in Austria. The main therapeutic areas of dronabinol are pain and palliative medicine as well as oncology and neurology, covering a broad spectrum of chronic and severe diseases. The C³ Group has two GMP (Good Manufacturing Practice)-compliant production facilities in Germany: while Spectrum Therapeutics GmbH in Neumarkt concentrates on the extraction of natural dronabinol from cannabis flowers, THC Pharm GmbH The Health Concept in Frankfurt focuses on the synthetic production of dronabinol and CBD.

AB Cernelle

AB Cernelle is a pharmaceuticals company that has been producing herbal pharmaceuticals from high-quality pollen extracts since 1953. By deploying state-of-the art technology and qualitative research and development, the company has developed the API Cernitin™ from pollen extract, which is processed in the form of tableting powder and ready tableting blends. This phytopharmaceutical is used to treat urinary tract diseases such as benign prostate hyperplasia and chronic prostatitis.

To the website